Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy

NCT00108108 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped Slow enrollment and minimal preliminary biological and clinical efficacy.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals

Collaborators